As of Jul 31
| +0.10 / +4.18%|
The 5 analysts offering 12-month price forecasts for TearLab Corp have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +80.72% increase from the last price of 2.49.
The current consensus among 5 polled investment analysts is to Buy stock in TearLab Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.